导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 39.83% | 84/1050 |
| 近一周 | 5.32% | 3/1104 |
| 近一月 | -8.67% | 969/1102 |
| 近一季 | -19.14% | 956/1092 |
| 近半年 | 16.36% | 186/1070 |
| 近一年 | 35.95% | 127/1018 |
| 近两年 | 96.23% | 205/926 |
| 近三年 | 29.80% | 396/834 |
| 成立以来 | -28.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
10.42% 40/1070 |
84.17% 91/1101 |
- - |
- - |
| 2025 | 26.33% 557/1065 |
3.61% 508/1014 |
1.02% 612/1038 |
23.73% 490/1050 |
-2.46% 588/1065 |
| 2024 | -21.63% 914/1011 |
-13.31% 868/960 |
-6.33% 708/983 |
9.63% 649/991 |
-11.96% 954/1011 |
| 2023 | -16.41% 577/952 |
4.31% 359/880 |
2.00% 100/895 |
-15.42% 782/915 |
-7.11% 686/952 |
| 2022 | -19.66% 313/867 |
-18.66% 454/773 |
10.71% 239/806 |
-5.96% 79/845 |
-5.15% 654/867 |
| 2021 | 2.40% 331/740 |
-9.50% 480/580 |
24.27% 98/659 |
-17.09% 636/704 |
9.82% 88/740 |
| 2020 | 44.22% 272/554 |
-2.15% 219/419 |
23.95% 211/466 |
1.90% 403/517 |
16.69% 173/554 |
| 2019 | 33.77% 270/410 |
28.48% 463/1149 |
-7.04% 858/1231 |
3.14% 248/390 |
8.60% 213/410 |
| 2018 | -36.55% 270/349 |
- - |
- - |
- - |
-11.18% 411/1080 |
| 2017 | 0.99% 177/285 |
- - |
- - |
- - |
- - |
| 2016 | -22.65% 129/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 华夏领先股票 VS. 东吴新产业精选股票A(580008) |